SELLAS Life Sciences
SLS
SLS
29 hedge funds and large institutions have $4.32M invested in SELLAS Life Sciences in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2% less capital invested
Capital invested by funds: $4.42M → $4.32M (-$99.6K)
1.47% less ownership
Funds ownership: 10.65% → 9.18% (-1.5%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
29
Holding in Top 10
–
Calls
$2M
Puts
$71K
Top Buyers
| 1 | +$131K | |
| 2 | +$102K | |
| 3 | +$85.7K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$61.3K |
| 5 |
OCG
Opus Capital Group
Cincinnati,
Ohio
|
+$46K |
Top Sellers
| 1 | -$246K | |
| 2 | -$202K | |
| 3 | -$108K | |
| 4 |
Renaissance Technologies
New York
|
-$45K |
| 5 |
JPMorgan Chase & Co
New York
|
-$7K |